Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Procrit
Pharma
FDA denies Akebia med, a 2nd blow to the oral anemia class
The FDA has issued a complete response letter to Akebia and Otsuka, denying their bid for approval of vadadustat to treat anemia associated with CKD.
Kevin Dunleavy
Mar 31, 2022 8:25am
Under stepped-up copycat attack, J&J expects growth to bottom out
Apr 16, 2019 11:49am
AZ, FibroGen's roxadustat nabs blockbuster China approval
Dec 18, 2018 12:00pm
Pfizer rolls out Retacrit at big discount to Amgen, J&J drugs
Nov 14, 2018 11:56am
New launches, uses to fuel growth, Johnson & Johnson execs say
Sep 14, 2018 7:05am
J&J's Remicade stands strong as Xarelto, Invokana suffer
Apr 18, 2017 11:23am
